Posted:
10/8/2024, 7:51:03 AM
Location(s):
Massachusetts, United States ⋅ Boston, Massachusetts, United States
Experience Level(s):
Senior
Field(s):
Medical, Clinical & Veterinary
When our people share why they join Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we’re driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we’re doing this with extraordinary science and awesome people (affectionately called Rapptors).
Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials for neuropathic pain and bipolar disorder.
The strength of Rapport comes from our Rapptors – who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you’re as excited about this opportunity as we are!
Responsibilities:
Requirements:
Rapport Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Note to Employment Agencies: Please do not forward any agency resumes. The company will not be responsible for any fees related to resumes that are unsolicited.
CCPA disclosure notice can be found here.
Website: https://www.rapportrx.com/
Headquarter Location: Boston, Massachusetts, United States
Employee Count: 11-50
Year Founded: 2022
IPO Status: Private
Last Funding Type: Series B
Industries: Biotechnology ⋅ Health Care ⋅ Life Science ⋅ Medical ⋅ Precision Medicine